{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:37:39Z","timestamp":1758191859775,"version":"3.44.0"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s547569","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T13:40:13Z","timestamp":1758116413000},"page":"8463-8474","source":"Crossref","is-referenced-by-count":0,"title":["Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Ruoyang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-3401","authenticated-orcid":true,"given":"Meiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangshun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuheng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3674-1946","authenticated-orcid":true,"given":"Zhenchuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1113216","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(19)30863-0","volume":"21","author":"Swain","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1200\/JCO.2011.35.0868","volume":"29","author":"Perez","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1200\/JCO.2014.55.5730","volume":"32","author":"Perez","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(16)32616-2","volume":"389","author":"Cameron","year":"2017","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/JCO.20.01204","volume":"39","author":"Piccart","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1200\/JCO.2016.67.4887","volume":"35","author":"Perez","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"Verma","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S1470-2045(17)30312-1","volume":"18","author":"Di\u00e9ras","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1470-2045(17)30313-3","volume":"18","author":"Krop","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref12","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology: breast cancer. Version 5.2020. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed July 15, 2020."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JOP.18.00290","volume":"14","author":"Giordano","year":"2018","journal-title":"J Oncol Pract"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/tbcr.2020.03.05","volume":"1","author":"Li","year":"2020","journal-title":"Transl Breast Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1200\/JCO.19.00108","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1016\/S1470-2045(19)30568-6","volume":"20","author":"Gourd","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1470-2045(20)30702-6","volume":"22","author":"Xu","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1021\/bi901810u","volume":"49","author":"Smith","year":"2010","journal-title":"Biochemistry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(11)60070-6","volume":"377","author":"Cortes","year":"2011","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13063-020-04341-y","volume":"21","author":"Yamashita","year":"2020","journal-title":"Trials"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.1007","volume":"42","author":"Yamashita","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2019.02.002","volume":"112","author":"Yuan","year":"2019","journal-title":"Eur J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(22)02420-5","volume":"401","author":"Hurvitz","year":"2023","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1470-2045(15)00540-9","volume":"17","author":"Harbeck","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0300891619887225","volume":"106","author":"Lutrino","year":"2020","journal-title":"Tumori"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12916-023-02999-0","volume":"21","author":"Cao","year":"2023","journal-title":"BMC Med"},{"key":"ref28","first-page":"2562","volume":"25","author":"Sarici","year":"2020","journal-title":"J BUON"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/107077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/107077","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T13:40:21Z","timestamp":1758116421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/eribulin-plus-pyrotinib-in-trastuzumab-resistant-her2-positive-advance-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/dddt.s547569","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}